Recruiting studies: Immunochemotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
Phase 3 · 1 location(s) · XIANG YANQUN · NCT06383780 Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06452602 Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant
Phase N/A · 1 location(s) · Tongji Hospital · NCT07088354 Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
Phase 2 · 5 location(s) · University Hospital, Bonn · NCT06810609 Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantati
Phase 2 · 1 location(s) · The Affiliated Hospital of Xuzhou Medical University · NCT07680933 Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stag
Phase 2 · 25 location(s) · Intergroupe Francophone de Cancerologie Thoracique · NCT06656598 Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Phase 3 · 49 location(s) · Fondazione Italiana Linfomi - ETS · NCT04442412 Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unres
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07086469 Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo
NA · 1 location(s) · Wen-zhao ZHONG · NCT07612722 Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Phase 2 · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT07167160 ZR2 Sequential Immunochemotherapy for Newly Treated MCL
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT05992597 A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPS
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT07133958 A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esoph
NA · 2 location(s) · The Central Hospital of Lishui City · NCT06792786 Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC
Phase 2 · 1 location(s) · Tang-Du Hospital · NCT07452601 A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatme
Phase 2 · 30 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06566586 Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platin
Phase 3 · 1 location(s) · Yang Hong · NCT06598527 Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer
Phase 2 · 1 location(s) · Sichuan University · NCT06403878 Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Rel
Phase 2 · 21 location(s) · Fondazione Italiana Linfomi - ETS · NCT05249959 PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma
Phase 2 · 1 location(s) · National Research Center for Hematology, Russia · NCT07209059 Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07003620 Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Phase 3 · 1 location(s) · Henan Cancer Hospital · NCT04280822 Neoadjuvant Immunochemotherapy for LAOSCC
Phase 3 · 1 location(s) · Lai-ping Zhong · NCT06258811 LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Phase 1 · 2 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06848465 Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
Phase 2 · 7 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07733830 PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemother
Phase 3 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05980715 Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05170503 Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
Phase 2 · 1 location(s) · Sichuan University · NCT06603402 Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
Phase 2 · 1 location(s) · Baylor College of Medicine · NCT05870800 Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NS
Phase 2 · 40 location(s) · CatalYm GmbH · NCT07098988 Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
Phase N/A · 20 location(s) · Fondazione Italiana Linfomi - ETS · NCT05524298

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.